Jump to content

Breast cancer patients to get access to two additional drugs under universal health program


snoop1130

Recommended Posts

Breast cancer patients to get access to two additional drugs under universal health program

 

79121698_2579820228752846_6772546943366201344_o.jpg

 

From December 16th, cancer patients will have direct access to two additional cancer treatment drugs under Thailand’s universal health scheme, avoiding the current pay first, refund later scheme.

 

Ms. Wilawan Payanoi, deputy director-general of the Comptroller Department, said today that the department has added Trastuzumab and Ruxolitinib to the OCPA system approved medication list.

 

Trastuzumab is used in the initial treatment of breast cancer when cancerous cells are multiplying rapidly, whereas Ruxolitinib is for patients suffering from Myelofibrosis, a cancer of the bone marrow.

 

Doctors who need the two drugs to treat their patients under the universal health scheme must register to get access to them.

 

Source: https://www.thaipbsworld.com/breast-cancer-patients-to-get-access-to-two-additional-drugs-under-universal-health-program/

 

thaipbs.jpg

-- © Copyright Thai PBS 2019-12-10
Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...